Updating on Bone and Soft Tissue Sarcomas Staging

Bone and soft tissue sarcomas consist of a heterogeneous group of malignant tumors of mesenchymal origin that can affect patients from any age. The precise staging of these lesions determines the best therapeutic strategies and prognosis estimates. Two staging systems are the most frequently used: t...

Descripción completa

Detalles Bibliográficos
Autores principales: Guedes, Alex, Oliveira, Marcelo Bragança dos Reis, Costa, Flávia Martins, de Melo, Adelina Sanches
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405264/
https://www.ncbi.nlm.nih.gov/pubmed/34483382
http://dx.doi.org/10.1055/s-0040-1710331
Descripción
Sumario:Bone and soft tissue sarcomas consist of a heterogeneous group of malignant tumors of mesenchymal origin that can affect patients from any age. The precise staging of these lesions determines the best therapeutic strategies and prognosis estimates. Two staging systems are the most frequently used: the system proposed by the University of Florida group, led by Dr. William F. Enneking (1980) and adopted by the Musculoskeletal Tumor Society (MSTS), and the system developed by the American Joint Committee on Cancer (AJCC) (1977), currently in its 8 (th) edition (2017). This paper updates the reader on the staging of bone and soft tissue sarcomas affecting the musculoskeletal system.

Ejemplares similares